The effectiveness of a surveillance program for breast cancer recurrence in extending survival is predicated on two assumptions: 1) most recurrences are detected at an early stage at surveillance visits; and 2) the early treatment of recurrence offers a better chance of cure or longer survival.
However, the data suggest that neither of these two assumptions is correct, and that postoperative follow-up of patients with breast cancer is expensive and does not significantly extend survival.
Mots-clés Pascal : Analyse coût efficacité, Etude longitudinale, Homme, Femelle, Recidive, Survie, Tumeur maligne, Glande mammaire, Glande mammaire pathologie
Mots-clés Pascal anglais : Cost efficiency analysis, Follow up study, Human, Female, Relapse, Survival, Malignant tumor, Mammary gland, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0482909
Code Inist : 002B20E02. Création : 199406.